Substituted propanamides as inhibitors of nucleases
|Year of publication
|MU Faculty or unit
|United States Patent and Trademark Office
|Compounds represented by the structural formula (1) where R1, R2, R3, R4, R5, R6 are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.